1H-NMR-based metabolomics identifies disrupted betaine metabolism as distinct serum signature of pre-frailty

被引:0
作者
Carmen Marino [1 ]
Alberto Imarisio [2 ]
Clara Gasparri [3 ]
Enza Napolitano [4 ]
Anna Di Maio [1 ]
Micol Avenali [5 ]
Gabriele Buongarzone [6 ]
Caterina Galandra [7 ]
Marta Picascia [8 ]
Manuela Grimaldi [7 ]
Francesco Errico [8 ]
Mariangela Rondanelli [3 ]
Anna Maria D’Ursi [8 ]
Enza Maria Valente [1 ]
Alessandro Usiello [6 ]
机构
[1] Department of Pharmacy, University of Salerno, Fisciano, Salerno
[2] Department of Molecular Medicine, University of Pavia, Pavia
[3] Neurogenetics Research Centre, IRCCS Mondino Foundation, Pavia
[4] Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona “Istituto Santa Margherita”, University of Pavia, Pavia
[5] Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, Università degli Studi della Campania “Luigi Vanvitelli”, Caserta
[6] CEINGE Biotecnologie Avanzate Franco Salvatore, Naples
[7] Department of Brain and Behavioral Sciences, University of Pavia, Pavia
[8] Parkinson’s Disease and Movement Disorders Unit, IRCCS Mondino Foundation, Pavia
[9] Department of Agricultural Sciences, University of Naples “Federico II”, Portici
[10] Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia
来源
npj Aging | / 11卷 / 1期
关键词
D O I
10.1038/s41514-025-00218-z
中图分类号
学科分类号
摘要
Increasing evidence suggests that frailty results from a complex age-associated metabolic decline. Here, we investigated the serum metabolomic profile of a well-characterized cohort of elderly subjects encompassing the whole fit-to-frail continuum. Enrichment analyses revealed a complex dysregulation of amino acids and energy metabolism in both pre-frail and frail participants. Remarkably, upregulated betaine levels emerged as a specific biochemical signature of pre-frail females, holding promise for the development of novel targeted interventions. © The Author(s) 2025.
引用
收藏
相关论文
共 39 条
  • [1] Hoogendijk E.O., Et al., Frailty: implications for clinical practice and public health, Lancet, 394, pp. 1365-1375, (2019)
  • [2] Fried L.P., Et al., Frailty in older adults: evidence for a phenotype, J. Gerontol. Ser. A Biol. Sci. Med. Sci, 56, pp. 146-157, (2001)
  • [3] Trevisan C., Et al., Factors influencing transitions between frailty states in elderly adults: the progetto Veneto Anziani longitudinal study, J. Am. Geriatr. Soc, 65, pp. 179-184, (2017)
  • [4] Gill T.M., Gahbauer E.A., Allore H.G., Han L., Transitions between frailty states among community-living older persons, Arch. Intern. Med, 166, pp. 418-423, (2006)
  • [5] Moqri M., Et al., Biomarkers of aging for the identification and evaluation of longevity interventions, Cell, 186, pp. 3758-3775, (2023)
  • [6] Imarisio A., Et al., Serum dysregulation of serine and glycine metabolism as predictive biomarker for cognitive decline in frail elderly subjects, Transl. Psychiatry, 14, (2024)
  • [7] Marino C., Et al., Fibromyalgia and depression in women: an 1H-NMR metabolomic study, Metabolites, 11, (2021)
  • [8] Arosio B., Picca A., The biological roots of the sex-frailty paradox, Exp. Gerontol, 198, (2024)
  • [9] Escarcega R.D., Et al., Serum metabolome profiling in patients with mild cognitive impairment reveals sex differences in lipid metabolism, Neurobiol. Dis, 204, (2025)
  • [10] Shekarchian A., Et al., Exploring the metabolomics profile of frailty- a systematic review, J. Diab. Metab. Disord, 23, pp. 289-303, (2024)